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Abstract 
Novel psychoactive substances (NPS), previously known as ‘legal highs’, have been 
common in the UK for many years (EMCDDA, 2018). The aim of this research work 
was to combine spectroscopic analysis with review of literature to assess the trends 
arising from the use of novel psychoactive substances in the UK. 
Handheld Raman Spectroscopy was used to analyse the contents of samples taken 
from the amnesty bin placed by Avon and Somerset constabulary at the Glastonbury 
Festival in 2011. These drug samples were then requested by Professor M. David. 
Osselton for analysis at Bournemouth University in 2011.  The novel use of handheld 
Raman was utilised to test the limitations of the technique. It was also used to give 
primary information about the type of substances being used during this time. Of all 
the samples scanned, 48.5% were Raman active; spectra were yielded for all the 
Raman active substances.  
A review of the literature took place, with the use of Boolean operators to 
systematically search for contemporaneous literature. The use of key words, such as 
‘novel’, ‘psychoactive’, ‘substances’, with defining key words such as, ‘prevalence’, 
‘use’, to refine the articles for inclusion.  By reviewing the literature it showed the 
need for intervention, how the government primarily responded and then how this 
finally culminated in the Psychoactive Substances Act 2016. 
With a combination of sciences and methods it has allowed for the critical 
discussion of the trends surrounding NPS and this thesis is the culmination of this 
work. 
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Introduction 
 Novel psychoactive substances (NPS) have been under review for the past 
decade and longer. Within the European Union, the early-warning system has been in 
place since 2007, to monitor the prevalence of NPS from drug seizures within member 
states (European Monitoring Centre for Drugs and Drug Addiction, 2007). The early-
warning system is inclusive of all member states to submit when seized, any new 
psychoactive substance after toxicological testing. By submission, these samples would 
then be reviewed by the joint European Monitoring Centre for Drugs and Drug Addiction 
(EMCDDA)-Europol commission. After the early-warning system was implemented, the 
number of seizures and NPS coming to the market has been tracked and has been ever-
rising since then (EMCDDA, 2018). In the UK, the problem peaked in severity when the 
deaths had nearly doubled from 2012 to 2013 from NPS usage (Office for National 
Statistics, 2013). In December 2013, the UK Government convened an expert panel on 
NPS, where their recommendations were amongst many, to ban NPS (Panel, 2014). This 
came to fruition in 2016, whereby the Psychoactive Substances Act became enforced 
across the UK. It banned the production, importation and the supplying of substances, 
which are ‘capable of producing a psychoactive effect in a person who consumes it’ 
(Psychoactive Substances Act, 2016, Ch. 2, s1, ss. a). Exemptions were made for 
medicaments, foods or foods used for physiological benefit, so the caffeine in coffee, 
food supplements such as turmeric capsules, or the nicotine in tobacco were exempt 
from the Act. Further discussion into substances and the associated psychoactive effect 
takes place in section 5. 
 Defining NPS is also key during this research. With the media calling NPS, “legal 
highs” (BBC, 2018), (The Telegraph, 2018), this brings about the notion that because 
something is legal it is therefore, safe (Sheridan, 2010).  
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To limit confusion, Novel Psychoactive Substance will be used in preference to terms such 
as ‘legal highs’ throughout this thesis. 
A further distinction is that of the use of existing medicaments for the purpose of 
bringing about a psychoactive experience, such as the smoking of hyoscine butylbromide, 
(Jalali et al., 2014) or the insufflation of gabapentin (Evoy et al., 2018). Medicaments were 
excluded as psychoactive substances from the Psychoactive Substances Act 2016, those 
substances listed as controlled, such as morphine are dealt with as part of the Misuse of 
Drugs Regulations 2001. The MDR 2001 allows for the legal use of substances which 
would otherwise be illegal if there was not a medical benefit for their use.  The use of 
medicaments in a novel way shall therefore not be considered as a novel psychoactive 
substance during this research.  
This research project incorporates both experimental and literature-based findings.  
Utilising systematic review to assess the trends arising from NPS in the periods 2011 – 
2015, then from 2016 after the introduction of the Psychoactive Substances Act to the 
present to assess trends since the introduction of the Act.  In the experimental arm, 
Raman spectroscopy will be used to analyse the contents of samples taken from the 
amnesty bin at Glastonbury Festival 2011. These samples were discarded voluntarily by 
the attending members of the festival. They were of varying form, shape and colour. A full 
description of all samples was taken during scanning, however access to this document 
was restricted whilst the research project was ongoing. Therefore, a full breakdown 
cannot be provided regarding the nature of the substances. 
Use of Raman Spectroscopy will be two-fold, firstly, to investigate whether handheld 
Raman spectroscopy can be used in rapid-scanning of NPS. Secondly, it will be utilised to 
see how prevalent NPS were before any major controls were in place from the 
Government. The overall aim of this research is to critically trends emerging from the use 
of NPS. 
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Objectives; 
o Investigate the contents of Glastonbury 2011 samples, with the use of handheld 
spectroscopic techniques.  
o Evaluate trends in the years 2011 – 2015, with the use of contemporaneous 
literature. 
o Assess the current prevalence of use and understand policy, using current literature. 
 
During the experimental arm of this research the Bruker BRAVO Duo, handheld 
Raman analyser was utilised. The basis of which Raman spectroscopy utilises the, ‘Raman 
effect’ of the inelastic scattering of light; by using a monochromatic beam of light in the 
IR region of the electromagnetic spectrum. When the light interacts with a molecule, if it 
can bring about, ‘a change in polarisability’ in the molecule, it will be Raman active. 
Raman spectroscopy is quick and efficient at yielding spectra.  
In practice this ‘change in polarisability’ is the stretching of the bonds within the 
molecule. As seen in figure 1, two ways in which a bond can stretch is symmetrical and 
asymmetrical.  
 
 
 
 
 
As the bond stretches symmetrically bringing both hydrogen atoms closer or 
rebounding away, this will induce a dipole moment where the nitrogen will become 
slightly positive or negative, and hence changes its polarisability. In infrared spectroscopy, 
this change in polarisability is not necessary and IR spectroscopy can detect asymmetrical 
bond stretches amongst others. 
N 
H H 
N 
H 
H 
Figure 1 - diagram showing the principle of Raman activity, with bonds 
stretching symmetrically and asymmetrically respectively. 
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It does, however, have its drawbacks, this being it is a surface level technique, so if 
there are multiple Raman active chemicals in a sample, then there will be possible 
masking. A further in-depth discussion of Raman spectroscopy can be found in chapter 
3.1. Raman spectroscopy will be used in this research because of its versatility and quick 
results. When compared to other techniques, such as chromatography which can take 
anywhere between 5-90 minutes, Raman is ideal for quickly yielding results. Further, 
Raman can analyse samples through certain substrates, such as some plastic bags, quartz 
and glass. This is ideal as the samples will remain in their storage containers and do not 
need any sample preparation to be analysed. The technique is also non-destructive, so 
the sample can be retained for future analysis.  
Whilst most of these advantages exist within the field of Spectroscopy, Raman was 
chosen for a couple of reasons. The first being the little-to-none interaction with quartz 
or silica-based glass. For example, infrared-red spectroscopy will have to some degree an 
interaction. This is somewhat negated in near-IR, however another advantage Raman has 
is the fact it will yield only a spectrum for the most prolific Raman active substance in a 
mixture. When analysing drug mixtures this is hoped to be advantageous. Most drugs are 
cut with bulking agents, with Raman it is hoped that only the active drug will be seen in 
the spectrum. With IR, there can be overlapping with mixtures which could obscure 
identification.  
 Statistical Analysis 
Statistical analysis was used during this research to identify correlations in the data 
gained from the scanning of Glastonbury samples, the scheme of which can be found in 
chapter 2.1. After the Raman analyser had been used, but before the spectra could be 
analysed, the data needed to be sorted so that alike compounds are grouped together for 
identification. Statistical analysis is the most efficient and effective way of doing this grouping. 
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The statistical analytical tools used were principle component analysis (PCA), k-means 
clustering and hierarchal clustering.  
 
Data Collection 
The substances for analysis were self-surrendered by attending members of the 
Glastonbury festival 2011. Amnesty bins were placed by Avon and Somerset Constabulary for 
attendees to discard of any illicit materials without any legal repercussions. Each of the 
samples were collected on each day of the festival from Thursday 23rd through to Sunday 26th 
June 2011.  
Before this research the original samples wrappings were discarded when transferred 
into glass vials. This work was undertaken by Bournemouth Students on the MSc Toxicology, 
by research under the supervision of Professor M. D. Osselton, when transferred the samples 
were assigned a batch letter and number. The batch letter corresponds to the day on which 
the substance was placed into the amnesty bin; Thursday was batch A and each day 
subsequent being, batch B, C and D. 
In total there were 260 samples across all four batches, however not all were Raman 
active. Three scans were taken of each sample, totalling 607 scans. In total 126 samples were 
Raman active and scans were able to be taken giving 378 scans able for analysis.  
Data Manipulation 
The three scans for each sample were loaded into Spectragryph v1.2.1, the mean-
average was taken of each, to yield one spectrum to be smoothed. Standard normal 
variates (SNV) was used to smooth the averaged spectrum, which was then derivatised. 
First-order derivative was used, which is the rate of change of intensity against wavelength 
(Owen, 1995).  
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For the statistical manipulation, RStudio version 3.6 was used. The PCA models, scree 
plots, k-means plots and dendrograms were all produced with RStudio v3.6.  
Principles 
Principle component analysis (PCA) is a statistical analysis tool used for multivariate 
analysis, it compares variables from a group of samples, e.g. population groupings and blood 
types, table 1. This is based upon the variance, which is defined as data-distance from the 
mean. Thus, alike data will group together having similar variances. 
Table 1- Example of blood types within population groups. 
 
These samples could then be plotted in order of value and a correlation will start to 
be seen, see Figure 2. As can be seen in the example, population 1, 2 and 3 group 
together, with 4 and 5 grouping together. 
Figure 2 – Graphical Representation of Table 1, showing an example of blood types amongst population. 
The key corresponds to the population groups in Table 1. 
 Population 1 Population 2 Population 3 Population 4 Population 5 
Type A 10 7 9 2 2 
Type B 8 9 6 1 3 
Ty
p
e 
A
Type B
1
2
3
4
5
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The centre of the dataset is then calculated by taking the median average, then the 
dataset is shifted so the average of the data becomes the origin (Miller and Miller, 1988). It 
should be noted this shift in the data does not change the relative positions of the data; 
Figure 3 shows this shift. Once this data has been shifted a trend line can then be put in that 
goes through the origin. To decide whether the line is of best fit, the line should minimise the 
distance from the data points to the line. 
 
Figure 3 – graph displaying the same data points as Figure 2, with the data having been ‘centre-shifted.’ Centre-shift is to 
place the mean of the data group upon the origin (0,0). 
As can be seen in Figure 4, the trend line in (a) has minimised the distance from the 
data points whilst remaining the best fit, unlike (b) which has greater distance from the data 
points therefore not being of best fit. This trendline is called Principle Component 1 (PC1), 
from it is taken the gradient, which in this example is 0.75. Using trigonometry, what is 
termed singular vector can be calculated, this is as if a triangle were in place, with PC1 being 
the hypotenuse, the distance of the hypotenuse is the single vector (Miller and Miller, 1988). 
Ty
p
e 
A
Type B
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For the PC1, the opposite and adjacent sides of the triangle calculation will become known as 
the loading scores. In this example, the loading scores would be 0.9 and 0.0998, this is the 
ratio for PC1 that type A and type B is found for this dataset (Graham, 1993). 
 
Figure 4 – Diagram showing the optimal placement of a trendline using the example dataset, blood types amongst 
population. (a) shows optimal placement as it crosses the origin, minimises the distance from the datapoint whilst remaining 
of best fit. (b) shows how a trendline of non-optimal placement as it does not minimise the distance from all datapoints, 
whilst remaining of best fit. 
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To calculate PC2 for a 2-D system, this is simply adding a line at a right angle to PC1, 
also going through the origin (Miller and Miller, 1988). Once PC1 and PC2 are in place, the 
original axis can be removed, and the PC axes are then rotated so they become the x and y 
axis. Figure 5 shows the PCs after the axes have been removed, before being rotated. 
 
Figure 5 – a diagram showing the placement of principles components in red (PC1) and blue (PC2) using the example 
dataset, blood types amongst populations. 
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The loading score is then squared before being divided by the total variance. For this 
example, the 0.9 and 0.0998 would become 99.9% and 0.998%, meaning that blood type A 
accounts for 99.9% of the variance in the population groups and blood type B accounts for 
0.998% of variance in the population groups. The variance will then be plotted onto a scree 
plot, Figure 6 shows a scree plot for the example. Figure 7 shows the complete PCA model. 
Principle component analysis can be used to find correlations in datasets. Using the 
example PCA, the grouping in the right upper quadrant may suggest that in the two separate 
population samples, there may be a link, such as being the in the same ethnic group. This 
principle has been used during the experimental arm of this research with cluster analysis. 
Cluster analysis can be done with the use of statistics; k-means analysis analyses the 
distance a datapoint is to the cluster mean; the datapoint then gets grouped to the closest 
cluster mean (MacQueen, 1967). K-means analysis may not always choose the best fit, so 
many iterations can be processed to assess how many clusters are statistically ideal.  
Figure 6 – The scree plot from the principle component analysis of the example dataset, blood types amongst 
populations. 
PC1 (99.9%)
PC2 (0.998%)
Figure 7 – The completed PCA model for the example dataset blood types amongst populations. 
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The Hartigan-Wong (1979) algorithm is used during this research; this assigns a random 
number for the start of the iterations, meaning a wide variety clusters can be analysed. These 
iterations can be plotted to a line graph, as seen in Figure 8. 
From the plot the ideal number of clusters is seen as the point before there is a 
plateau. In the example plot, this would be 3 clusters.  Once the ideal number of clusters 
has been calculated it then needs to be visualised so the datapoints can be grouped for 
further analysis.  
Dendrograms are the visualisation of hierarchical clustering. Like k-means clustering, 
hierarchal clustering is based on distance. The mid-point distances between to datapoint joins 
the two datapoints and become a single representation of two datapoints, this is known 
agglomeration, shown in Figure 9. 
 
Figure 8 – A k-means plot for the example dataset, blood types amongst populations. 
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As with k-means clustering, the datapoints that are close in distance will more than 
likely be alike in nature, so the single datapoint will cluster alike datapoints. A 
dendrogram is the visualisation of this clustering. This clustering can be taken one step 
further with the use of k-means clustering. Once the ideal number of clusters has been 
decided with k-means, this can then separate groups of data on the dendrogram into 
clusters that are alike. 
Experimental 
PCA was used to analyse each batch of substances individually. The aim was to 
identify clusters within the data which would then identify substances similar in class to 
be analysed for the contents. To facilitate this, each derivatised spectrum of each batch 
was loaded into an excel sheet, with the samples running sequentially across the 
columns. When the spectrum is produced by the Raman analyser, the sampling points 
along the wavelength will be the same across all spectra. These numbers are not included 
in the PCA as it is not needed to carry out the PCA. Figure 10 shows the excel sheet. 
Figure 9 – A diagram showing the process of agglomeration in a dendrogram. 
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Once the excel sheet had been compiled, it was then imported into RStudio, which 
computationally produces the PCA model. Once the PCA model has been produced, 
further statistical analysis can take place in RStudio which further processes the statistical 
manipulation. Figures 11 – 14, show each of the PCA models of each batch before any 
further statistical analysis took place; Appendix A shows the scree plots for each batch. 
 
 
 
 
 
Figure 10 – image of the excel sheet which has all the derivatised spectra in numerical data for batch A, ready for PCA computation in RStudio. 
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Figure 11 – PCA model for Batch A of the scanned samples taken from the amnesty bins place at the Glastonbury festival 2011, 
before any further statistical analysis has taken place. 
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Figure 12 – PCA model for Batch B of the scanned samples taken from the amnesty bins place at the Glastonbury festival 2011, before 
any further statistical analysis has taken place. 
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Figure 13 - PCA model for Batch C of the scanned samples taken from the amnesty bins place at the Glastonbury festival 2011, before 
any further statistical analysis has taken place. 
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Figure 14 - PCA model for Batch D of the scanned samples taken from the amnesty bins place at the Glastonbury festival 2011, before 
any further statistical analysis has taken place. 
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Whilst some clustering can be identified, K-means clustering was utilised to 
distinguish difficult to see clusters, with Figures 15 - 18 showing the line plots for each set of 
iterations. From each of the plots: Batch A saw that 5 clusters were ideal; Batch B had 5; 
Batch C had 3 and batch D had 4.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 15 – k-means plot for Batch A of the scanned samples taken from the amnesty bins 
placed at the Glastonbury Festival 2011. 
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Figure 16 – k-means plot for Batch B of the scanned samples taken from the amnesty bins placed at the Glastonbury Festival 
2011. 
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Figure 17 – k-means plot for Batch C of the scanned samples taken from the amnesty bins placed at the Glastonbury Festival 
2011. 
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 Figure 18 - k-means plot for Batch D of the scanned samples taken from the amnesty bins placed at the Glastonbury Festival 
2011. 
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A dendrogram was made for each of the batches. This showed the 
substances and how they clustered; Figures 19 – 21 show each batch. These clusters 
can then be projected onto the individual batch PCA model, which is seen in Figures 
22 – 25. The PCA model can then be checked to see if the k-means has the ideal 
number of clusters and whether the dendrogram has a good split of the data. The 
datapoint on the PCA in figures 22m-25, have been change to circles for ease of 
viewability. When checking the dendrogram spacing, the datapoint will correspond 
with a specific substance, e.g. A1, or B3. 
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Figure 19 – Dendrogram plot with the ideal number of clusters as obtained from k-means plot (Figure 15), 
the colours used to aid in differentiation of the clusters. This dendrogram is for batch A of the scanned 
samples taken from the amnesty bins placed at Glastonbury Festival 2011. 
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Figure 20 - Dendrogram plot with the ideal number of clusters as obtained from k-means plot (Figure 16), the colours 
used to aid in differentiation of the clusters. This dendrogram is for batch B of the scanned samples taken from the 
amnesty bins placed at Glastonbury Festival 2011. 
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Figure 21 - Dendrogram plot with the ideal number of clusters as obtained from k-means plot (Figure 17), the colours used 
to aid in differentiation of the clusters. This dendrogram is for batch C of the scanned samples taken from the amnesty bins 
placed at Glastonbury Festival 2011. 
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Figure 22 - Dendrogram plot with the ideal number of clusters as obtained from k-means plot (Figure 18), the colours used 
to aid in differentiation of the clusters. This dendrogram is for batch D of the scanned samples taken from the amnesty bins 
placed at Glastonbury Festival 2011. 
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Figure 23 - PCA model of Batch A of the scanned samples taken from amnesty bins placed at the Glastonbury Festival 2011. 
Ideal cluster groups have been identified, with colours aiding to separate the clusters for user ease. 
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Figure 24 - PCA model of Batch B of the scanned samples taken from amnesty bins placed at the Glastonbury Festival 2011. 
Ideal cluster groups have been identified, with colours aiding to separate the clusters for user ease. 
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 Figure 25 - PCA model of Batch C of the scanned samples taken from amnesty bins placed at the Glastonbury Festival 2011. 
Ideal cluster groups have been identified, with colours aiding to separate the clusters for user ease. 
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Figure 26 - PCA model of Batch D of the scanned samples taken from amnesty bins placed at the Glastonbury Festival 2011. 
Ideal cluster groups have been identified, with colours aiding to separate the clusters for user ease. 
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Unfortunately, these clusters do not correspond to alike clusters across the batches. To remedy this 
each of the batches were collated into an overall view. The same PCA, k-mean and dendrogram 
process took place, the results of which can be seen below in Figure 27 - 29. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 27 - PCA model for all batches of scanned samples taken from amnesty bins placed at the 
Glastonbury Festival 2011. 
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Figure 28 - k-means plot for all batches of scanned samples taken from amnesty bins placed at the Glastonbury Festival 
2011. 
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Figure 29 – Dendrogram plot for all batches of scanned samples taken from amnesty bins placed at the Glastonbury Festival 2011. k-
means clustering has been applied with colour to aid in differing the clusters. 
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Once this statistical analysis had taken place, the spectra for each of the clustered 
groups were compared to see if the substances were alike. It should be noted that k-means 
and hierarchal clustering give an approximation to the ideal clusters however may not be able 
to distinguish some groups. This was the case with a few of the statistically clustered groups 
so manual clustering also took place to give the final groups for identification which takes 
place in the next chapter. 
Raman Spectroscopy 
Principles  
Raman spectroscopy works on the basis of elastic and inelastic scattering of light 
when a monochromatic wave of light, ωi interacts with a material system. Elastic scattering of 
light is known as the Rayleigh scattering. This is when the energy a photon gives to a material 
system is released back to the same energy state, i.e., V0 to V1, then back down to V0. With 
inelastic scattering, the irradiating photon interacts with the material system, and the system 
will then vibrate. Depending on the type of vibration, depends whether something is Raman 
active. If the energy brings about, ‘a change in polarisability’, i.e., a symmetrical stretch of 
atoms in a bond, it is Raman active. (Whiffen, 1966) 
In practice, the monochromatic wave of light used, ωi is two coherent overlapping 
beams of light, ω1 and ω2; where ω1 > ω2. When either of these beams of light interact with a 
material system, the energy difference of the scattered photon, ωs will arise to the situation 
known as Stokes-Raman or anti-Stokes-Raman scattering (Long, 2002). The source of the 
monochromatic light is often a laser in Raman spectroscopy, this is as it only emits light at a 
specific wavelength as is needed for Raman.  
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Equation 1 Stokes-Raman Scattering 
ωs = ω2 – ωM.  
Equation 2 anti-Stokes-Raman Scattering 
ωs = ω1 + ωM. 
 
These equations are summed up in the energy-level diagram above, Figure 30. This is 
the inelastic scattering of light and it is what we are concerned with when using the Stokes-
Raman scattering effect in spectroscopy. This is as most molecules do not exist in an excited 
state before irradiating. 
Figure 30 – Energy diagram showing the Raman effect. The blue (left) shows Stokes-Raman scattering in the molecule energy going from 
ground state without returning to ground state. The green (right) show anti-stokes-Raman scattering, showing how an excited molecule will 
return to ground state from an excited state. 
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The spectra that are yielded during the experimental aspect are not expressed in 
terms of frequency, ω, but rather in wavenumber ῡ (unit cm-1). To convert from frequency to 
wavenumber, apply equation 3;  
Equation 3 Conversion from wavelength to wavenumber 
 
ῡ =  
ω
2πc
 
 
The Bruker BRAVO Duo Raman analyser emits an excitation laser at two different 
wavelengths as is the ‘Duo’ part of the BRAVO. These are at 700 and 1100nm and the two 
spectra are then stitched together to produce a spectrum across a greater range. It operates 
in the IR region of the electromagnetic spectrum. Unlike FTIR, the Raman works only at a 
specific wavelength of light, whereas FTIR will span the IR spectrum. Thus, Raman will yield 
results complimentary to IR but not exactly like such, due to the difference in the excitation 
wavelength. The difference also between Raman and IR spectroscopy is the way the energy 
will alter the molecule to cause a vibration. A symmetric stretch of a linear molecule will bring 
about a change in polarisability, which means it is Raman active. However, it does not induce 
dipole moment therefore is not IR active. An asymmetric stretch or bend will induce a dipole 
moment therefor is IR active, but not Raman active. Therefore, it is often said to be 
complimentary as one technique is able to analyse what the other may not (Whiffen, 1966).  
The BRAVO does not have user programmable parameters, but it is published in the 
user manual the BRAVO will operate at < 100 mW, for both lasers, so is low power. Although 
it is not programmable, the machine has been specifically made to work through the 
packaging of the material it is scanning. There will be some interactions between the laser 
and the glass vials, however when seen in the spectra this is minimal. 
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Another benefit of the BRAVO is its reduction of fluorescence in the spectra, which in 
other spectra can skew the results. Fluorescence is a similar process to Raman scattering; 
however, it differs during the relaxation cycle of the phonon. Where in Raman scattering, the 
phonon will be excited to a virtual state and relaxed to a slightly higher energy level. In 
fluorescence, the irradiating photon will interact with the material system, and the phonon 
will be elevated to an energy level.  
The phonon will then release energy before relaxation, this is called internal conversion. 
Fluorescence can overpower spectra so having a system which works to reduce fluorescence 
is ideal. 
 
Experimental 
After the data had been analysed and grouped as per chapter 2.2-4, the individual 
groups were then loaded into Spectragryph for identification and from this it was noted that 
the Bruker BRAVO Duo spectra that were yielded were reported in wavelength as opposed to 
Raman shift. The aforementioned, equation 3 was applied to each of the grouped data, then 
each batch within the groups were plotted as stacked spectra. This allows to see if there are 
any obvious differences between substances across batches. It also allowed for the functional 
groups to be identified and the substances subsequently identified.  
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 Figure 31 - Stacked spectra of identified cluster, now designated as group 1. All individual spectra for each of the batches for 
the identified group 1 were compiled to one spectrum per batch for ease of analysis. The blue line corresponds to batch A. 
The orange line corresponds to Batch B. The grey line corresponds to batch C. The yellow line corresponds to batch D.  
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Figure 31 shows the stacked spectra for group 1, the green coloured group from 
Figure 29. Major peaks are noted at 1600, 1280, 1275 and 860 cm-1. These correspond to a 1o 
amine, a methyl group, an aryl ketone and an ethyl ester. Therefore, it is postulated this 
spectrum is that of benzocaine, the structure of which is given in Figure 32. 
 
 
 
 
 
 
 
 
 
 
Figure 32- Chemical structure of Benzocaine 
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Figure 33 - Stacked spectra of identified cluster, now designated as group 2. All individual spectra for each of the batches for 
the identified group 2 were compiled to one spectrum per batch for ease of analysis. The orange line corresponds to batch 
A. The blue line corresponds to batch D. 
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Figure 33 shows the stacked spectra for group 2, the orange coloured group from the 
dendrogram in Figure 29. Major peaks can be seen at 715, 795, 920, 970, 1100 and 1236 cm-
1. These correspond with a 1,3- substituted benzene, aliphatic ether, an amine, an 
unsymmetrical benzene substitution, a halogenated aromatic and an ethyl join. Therefore, 
this substance is postulated to be 25I-NBOMe; the structure is given in Figure 34. 
 
 
 
 
 
 
 
 
 
 
 
Figure 34 - Structure of 25I-NBOMe 
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 Figure 35 - Stacked spectra of identified cluster, now designated as group 3. All individual spectra for each of the batches for 
the identified group 3 were compiled to one spectrum per batch for ease of analysis. The blue line corresponds to batch A. 
The yellow line corresponds to batch B. The orange line corresponds to batch D. 
52 
 
Figure 35 shows the stacked spectra of group 3, the red group seen in the 
dendrogram of Figure 29. Major peaks are noted at 990, 1105, 1285, 1530 and 1530 cm-1. 
This corresponds to an amine, a carbonyl, bisubstituted benzene, 1o amine and isopropyl 
structure. It is therefore postulated the substance for these spectra is 4-methyl 
methcathinone, commonly known as mephedrone; the structure is given in Figure 36. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 36 - Chemical structure of Mephedrone 
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Figure 37 - Stacked spectra of identified cluster, now designated as group 4. All individual spectra for each of the batches for 
the identified group 4 were compiled to one spectrum per batch for ease of analysis. The blue line corresponds to batch A. 
The orange line corresponds to Batch B. The grey line corresponds to batch C. The yellow line corresponds to batch D.  
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Figure 37 shows the stacked spectra for group 4, the yellow group in the dendrogram 
seen in Figure 29. Major peaks are noted at 675, 850, 875, 1150, 1525 and 1610 cm-1. These 
correspond with a bisubstituted benzene, a halo group, unsymmetrical benzene substitution, 
a methyl group and a 1o amine. It is therefore postulated that this substance is ketamine; the 
structure is given in Figure 38. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 38 - Chemical structure of Ketamine 
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Figure 39 - Stacked spectra of identified cluster, now designated as group 5. All individual spectra for each of the batches for 
the identified group 5 were compiled to one spectrum per batch for ease of analysis. The blue line corresponds to batch A. 
The orange line corresponds to Batch B. The grey line corresponds to batch C. The yellow line corresponds to batch D. 
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Figure 39 shows the stacked spectra for group 5, the pink coloured group in the 
dendrogram of Figure 29. Major peaks are seen at 950, 1100 and 1550 cm-1. These 
correspond with a primary alcohol, a butyl chain and a carboxylic acid. Therefore, it is 
postulated this substance is γ-Hydroxybutyric acid; the structure of which is given below in 
Figure 40. 
 
 
 
 
 
 
 
 
 
 
Figure 40 - Chemical structure of GHB 
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 Figure 41 - Stacked spectra of identified cluster, now designated as group 6. All individual spectra for each of the batches for 
the identified substance in group 6 were compiled to one spectrum per batch for ease of analysis. The blue line corresponds 
to batch A. The orange line corresponds to Batch B. The grey line corresponds to batch C. The yellow line corresponds to 
batch D 
58 
 
Figure 41 shows the stacked spectra for group 6, the dark blue colour found in the 
dendrogram in Figure 29. Major peaks are noted at 790, 910, 980, 1125, 1370 and 1430 cm-1. 
These correspond to a para-substitution, a methylene group, 1o amine, an isopropyl group, a 
methyl group and a NH bend. It is therefore postulated that the substance is MDMA, better 
known as ecstasy; the structure of which is given below in Figure 42.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 42 - Chemical structure of MDMA 
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Figure 43 - Stacked spectra of identified cluster, now designated as group 7. All individual spectra for each of the batches for 
the identified substance in group 7 were compiled to one spectrum per batch for ease of analysis. The blue line corresponds 
to batch A. The orange line corresponds to Batch B. The grey line corresponds to batch C. 
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Figure 43 shows the stacked spectra of group 7, the light blue coloured group seen in 
the dendrogram from Figure 29. Major peaks are seen at 850, 1100, 1300, 1425 and 1525 cm-
1. These correspond with a substituted benzene, a methylene bridge, an isopropyl chain, a 
methyl group and an amine. Therefore, it is postulated this substance is an amphetamine, the 
structure of which is given in Figure 44.  
 
 
 
 
 
 
 
To give a brief summary of the substances found during the experimental arm of this 
research, refer to table 2.  
Table 2 - Summary of the substances identified from the cluster groups. 
Group Substance 
1 Benzocaine 
2 25I-NBOMe 
3 Mephedrone (4-methyl methcathinone) 
4 Ketamine 
5 γ-Hydroxybutyric acid 
6 MDMA (Ecstasy) 
7 Amphetamine 
 
Figure 44 - Chemical structure of Amphetamine 
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Whilst the spectra seen from group 1 is of benzocaine, the physical properties of the 
some of the samples that were seen would indicate it is more likely to be that of freebase or 
‘crack’ cocaine; ‘street crack’ has been known to been adulterated with other local 
anaesthetics (Lapachinske, S et al., 2015). It should be noted that Raman spectroscopy will 
only report one substance of a mixture, one which is ‘more’ Raman active, in this case whilst 
benzocaine is seen, it could be assumed based on the physical properties and the knowledge 
this is street dealt drugs, this is more than likely a mixture with the drug of abuse being 
freebase cocaine. It, however, should also be noted that during this time period it become 
fashionable to mix benzocaine with other NPS and sell this product as a cheaper alternative to 
cocaine (Legally High, 2013), therefore it could also be likely that some of these substances 
scanned could also be the imitation cocaine. 
25I-NMBOMe, commonly known as ‘n-bomb’, or simply, ‘25I’ is a synthetic 
hallucinogen, a substituted phenylethylamine (Expert Committee on Drug Dependence, 
2014). At this time in 2011, 25I-NBOMe was not a controlled substance, however it was later 
advised by the ACMD that it be placed under a (temporary class drug order) TCDO (ACMD, 
2013). It is currently a Class A drug; at the time it was collected it would have been an 
uncontrolled novel psychoactive substance.  
Group 3 is 4-methyl methcathinone, more commonly known as ‘mephedrone’.  As a 
cathinone it is chemically related to amphetamine. Derived from the plant khat and 
chemically modified it acts as a stimulant. It was recommended by the ACMD in March 2010 
that it be placed in the Class B of substances. By the time these samples were then collected, 
it would have been a classified drug under the Misuse of Drugs Act 1971.  
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Group 4 is ketamine, which has medicinal uses both in humans and veterinary 
practices. It is used to start and maintain sedation, however the first known implication to its 
recreational use, was an anecdotal reference in the ‘The Fabulous Furry Freak Brothers’ comic 
dated to the early 70s (Shelton, 2008). When used recreationally it brings about a dissociative 
effect. 
Group 5 is γ-Hydroxybutyric acid (GHB), a GABAinergic drug used medically to treat 
seizure and narcolepsy. It has sedative like effects as it is an agonist of the GABA receptors, 
much like benzodiazepines or gabapentin. GHB has been a Class C drug in the UK since 2003 
so would have been a long-standing classified drug by the point of collection. 
Group 6 is 3,4-Methylenedioxymethamphetamine, MDMA, better known as ‘ecstasy’. 
It is a substituted amphetamine having been popular since the 80s, notable use within in the 
clubbing scene was seen, as MDMA gave a boost of energy when taken (Anderson, 2014). It 
has been a classified drug in the UK since 1977, when an amendment to the Misuse of Drugs 
Act 1971 was enforced.  
Group 7 is amphetamine, known as ‘speed’. When taken it given a boost to energy 
and increases awareness. It has medical uses however these have been severely reduced due 
to the high likelihood of abuse. It has been illegal in the UK since the introduction of the 
Misuse of Drugs Act 1971.  
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Figure 45 shows a pie chart, showing the percentages of how each substance is  
representative in the samples collected. It shows that the majority of use is shared with 
classical clubbing drugs MDMA and Ketamine. These samples were collected during the 
height of the NPS epidemic, so it would be expected there would be a higher number of NPS. 
It is worth noting that the average age of the Glastonbury attendee was 39 (Kienast, 2019), so 
this may show that this collection is not representative of the country as a whole at the time. 
6%
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21%
23%
Mephedrone 25I-NBOMe GHB Amphetamine
Benzocaine MDMA Ketamine
Figure 45 - Pie chart showing the proportion of each substance amongst all scanned substances of the samples taken from 
the amnesty bins placed at the Glastonbury festival 2011. 
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As is the nature with spectroscopy, when using correlation tables for the 
identification, it can often leave gaps in the interpretation. For a single wavenumber there 
may be many bands which it can correspond with.  
Figure 46, is an example correlation table, where it can be seen at 540cm-1 (the red line), 
there can be many compounds which the spectral peak can correspond 
 
 
 
 
 
 
 
 
 
 
This can leave it down to the interpreter to make the best judgment call, based on 
any physical properties, or the chemistry it will most likely be made up of. Therefore, each of 
the substances identified in this section has been highlighted as being, postulated. To confirm 
the interpreted identification, control samples of high purity would be scanned, and the two 
spectra would be assessed for spectral likeness. This, however, could not take place during 
this research due limitations beyond control, so these postulations remain uncertified.  
Raman spectroscopy will normally utilise a microscope for a pinpoint location on 
which the sample will be scanned. The sample is also often a thin film of material deposited 
onto a flat substrate, usually silicon. This can also be taken further, by enhancing the surface 
for scanning. By placing a thin film of gold nanoparticles, this can often enhance the spectra 
Figure 46 - Raman correlation table, with the red line highlighting 540cm-1, showing multiple bands at 
this locus. 
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yielded, this process being called Surface Enhanced Raman Spectroscopy (SERS). With 
handheld Raman, this pinpoint locus precision is not available, therefore there may be shift 
between the scanned surface between each scan.  
During this research, there sample was scanned through the container, which was made of 
silica-based glass. This had little interaction, with minimal-to-no effect of the resulting 
spectra, however the no SERS could take place. For this study this is negligible, as the use of 
handheld Raman spectroscopy was for rapid-scanning, and to study the capability of 
handheld Raman for scanning of NPS. 
 
Trends surrounding NPS in the period 2011 – 2015. 
2011 
This study is concerned with the change of trends within substance use, focussing on 
NPS. For this, the experimental arm of this study starts by analysing the contents of samples 
seized from the 2011 Glastonbury Festival. The Glastonbury Festival, the largest Greenfield 
festival in the world (Telegraph, 2017) is attended by hundreds-of-thousands of people 
yearly. The substances seized were from the ‘amnesty bin’ whereby festival attendees could 
safely dispose of any drug without any legal consequences of being in contact with that drug. 
The analysis found that there were a mix of classical drugs and novel substances. 
Whilst this is not exhaustive of the full extent of the trends during 2011, it is a small 
population hoped to be somewhat representative. In addition to this information, data 
garnered from other sources, such as the EU early warning system, was used to give the best 
insight possible as to the trends emerging.  
In 2010, the coalition government released a document to highlight its strategy for 
harm reduction. In which it indirectly used Wilson and Kelling’s (1982), ‘broken windows’ 
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theory. This theory states that if there are visible signs of the area being dilapidated there will 
be a higher level of crime in that area.  
The government pledged to make it so that the UK was no longer an appealing place for drug 
traffickers in an attempt to reduce the drug use in the UK, along with building communities 
back up so the population of the community felt there was other options than to form habits 
or addiction. In the same manifesto they stated that new powers would be introduced to 
control emerging NPS (Home Office, 2010). 
It was then in 2011, the UK introduced a new parliamentary power, this being the 
Temporary Class Drug Order. This gave parliament the power to class a substance as a 
controlled drug, therefore being under the complete effects of the Misuse of Drugs Act 1971 
(Home Office, 2011) for 12 months. 
In 2011, the European Monitoring Centre for Drug and Drug Addiction (EMCDDA), 
ranked the UK as the 5th highest European country by mortality relating to drugs by 
population (EMCDDA, 2012). Whilst it can be difficult to compare this statistic across the 
member states, as each have is own criteria on inclusion, it does show the high number of 
DRD; 2,334, for the UK (ONS, 2012).  
Also during this period, the Office for National Statistics (ONS), did not include a 
speciified group for inclusion into data for NPS, including DRD into exsisting group, such as as 
‘opioids’, etc (ONS, 2012). The number given by the ONS is also those numbers which were 
mentioned as a complication in the death certificate. Therefore, the true number of NPS 
related deaths may not be fully disclosed as corners may not have been testing for NPS, or 
put it down to another drug. 
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2012 
An explorative study from Scotland in 2012 highlighted the trends emerging - at least 
in Scotland, with regards to NPS. The study looked at drug related deaths (DRD), to see which 
drugs were most commonly seen, in special regards to NPS. The study noted that 
benzodiazepines and stimulants were highly used (McAuley, 2012). 
 This is in comparison with the experimental arm of this research, which shows that 
the likes of MDMA and amphetamine were highly used (33%). It was also worth noting the 
authors saw there was often a profile of mixing drugs with one another. 
 Koch et al. (2017), shows that users would often try and balance the up-down cycle 
with the use of benzodiazepines, alike to McAuley. By using benzodiazepines, it would make 
the down part of the cycle much easier on the user, however McAuley’s research may be 
seeing that benzodiazepines were in fact being used to balance the up down cycle, not being 
the drug of choice for users.  
An emerging trend in 2012 comes from the Office for National Statistics (ONS). The 
first dedicated section to NPS in the report on DRD appeared. This noted how there had been 
an increase in DRD implicated with NPS, from 29 to 52 (ONS, 2013). There was still a lack of a 
universal definition for NPS (ONS, EMCDDA 2013), with reports citing these substances as 
‘legal highs’ (Wilkins and Sweetspur, 2013, Baumeister, et al., 2015, Freeman, et al., 2010), or, 
‘new psychoactive substances’ (Larabi, et al., 2019, Kikura-Hanajiri, Kawamura and Goda, 
2013), or then ‘novel psychoactive substances (Wood and Dargan, 2013, Soussan and 
Kjellgren, 2016).  
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2013 
The problem with NPS had gained national attention with the public by 2013, when 
the media had started to cover the problem. This is highlighted by the commission of multiple 
TV documentaries and news reports. Such as Cherry Healey reporting on BBC3, the ‘youth-
side’ of BBC and ‘Legally high’ from Channel 4. Some of these TV documentaries noted how 
Trading Standards rules of no persons under 18 should be purchasing these substances and if 
the seller had any suspicion the buyer was going to consume it, the seller was obliged to 
refuse the sale. 
Some sellers however didn’t adhere to these standards (How To Get A Life, 2013), 
this is discussed further in chapter 5.  In the documentary Legally High, Professor David Nutt 
explains how the market for NPS was made by the media. The quality of classic drugs had 
been going down, when pure, legal chemical came to the market. The media went into a 
frenzy and this spiral perpetuated the sale of NPS, as the media was offering front page 
information, people would take it as they saw these substances in the news and it was legal, 
therefore the media further reported on it (Legally High, 2013). 
It was also in June 2013, the issues of the past years with NPS had been addressed in 
government. Ms Diana Johnson brought forward information regarding NPS such as how 
many substances had now been identified, how many had come to Britain and the effect it 
has had. She highlighted than in the two years since the government had the introduced 
temporary class drug orders, only one had been made with a 100 new NPS having come to 
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the market in the same two years (WH Deb 06 June 2013).  It was then in July that the 
problem was address in the commons (HC Deb 15 July 2013). 
 
 
2014 
In 2014, the UK Government convened the, ‘New Psychoactive 
Substances Review Expert Panel’. They had 6 months in which to review the situation 
surrounding the use and control of NPS and what would best be suited in the future to help 
protect the public. The review panel assessed how other countries had been affected and 
how they chose to deal with NPS, along with the evidence from within the UK to make an 
informed decision.  
 The review ultimately returned 5 options for the UK Government to restrict supply of 
these substances. These approaches included, analogue, neurochemical, general prohibition, 
full regulatory and restricted availability. The panel reached each of the recommendations by 
reviewing what other countries had done, and how successful it had worked in each country. 
For example, how the licensing system in New Zealand under the Psychoactive Substances 
Act 2013, whereby the sale of NPS is legal should it be licensed after human safety testing. 
Ultimately, the UK Government chose to take an approach which made an 
amalgamation of the approaches, this leading to the Psychoactive Substances Bill, becoming 
the Psychoactive Substances Act 2016. The resulting legislation banned the production, 
importation and supply of NPS, but possession was not made illegal unless in a custodial 
setting, or it was possessed with the intent to supply.  
2015 
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The issue with NPS had now started to take a toll on certain institutions within the UK, 
one of these being the NHS. Gilani reporting in 2016 of data collected in 2015, highlighted the 
struggle of a GP in treating a person who may have used NPS. She speaks of how treating 
somebody who is needs treatment for a classical drug of misuse, then the GP need only 
access ToxBase for guidelines, and prescribe the ‘antidote’.  
When a person presents who may have ingested a bit of ‘Charly Sheen’ or ‘Magic Dragon’, the 
case for treatment may not be as simple, for the patient may not know what the drug in the 
package is, and even if the packet says it is one thing, it is not always guaranteed to be that 
substance. In aid to try and combat this, The Novel Psychoactive Treatment UK Network 
(NEPTUNE), was founded in 2015 with the aim to give effective advice on the clinical 
management of patient who had taken NPS. They provided a comprehensive guide to the 
management of patients, and who the patients may be. They also go in-depth about the 
classes of substances most likely to encounter and how to effectively support those who may 
have taken them. 
By 2015, drug related deaths - with NPS implicated, had risen from 82 in 2014 to 114 in 
2015 (ONS, 2016). The ONS also reported that of the 114 death, 25 of those were from 
substances which at the time were legal. (ONS, 2016). This highlights the need for 
intervention, with people either assuming they’re safe because these substances are legal, or 
they do not know the detrimental effect many of these substances have due to the lack of 
testing and authorisation of safety. 
Government Responses 
Whilst the Psychoactive Substances Act 2016 was pivotal in controlling NPS, it was 
not the first control measure implemented by the Government. As previously mentioned, the 
Government introduced the ‘Temporary Class Drug Order’. This allowed for substances that 
posed a risk to public health, that were not previously covered by the Misuse of Drug Act 
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1971 to be banned (Misuse of Drugs Act, 1971, Ch. 2, s.2A). This power was given as an 
amendment to the Misuse of Drugs Act 1971 in 2010. It was upon the recommendation of 
the Advisory Council on the Misuse of Drugs (ACMD), that a substance should be banned. 
They made numerous recommendations for different substances to be banned, such as the 
NBOMe family and APB isomers to be banned (ACMD, 2013).  
Once a substance was banned under a TCDO, it was then treated as a controlled drug 
under the Misuse of Drugs Act. After the introduction of the Psychoactive Substances Act 
2016, TCDO fell out of favour; this was two-fold. First there is now a duality with the two Acts, 
substances not controlled under the Misuse of Drugs Act are now often controlled by the 
Psychoactive Substances Act, and so a TCDO is no longer needed to control these substances. 
Secondly, substances controlled by a TCDO are controlled by the Misuse of Drugs Act 1971 
and therefore any psychoactive substance under a TCDO found in a custodial setting cannot 
be tried under the Psychoactive Substances Act 2016. As it is not an offence to be in 
possession of a temporary class drug it is evident how this duality of the Acts is vital in 
understanding.  
Prior to the Psychoactive Substances Act 2016, there were multiple regulations in 
place from different sources, which were in place to ensure the safety of the buyer was 
maintained. These included, the Intoxicating Substances (Supply) Act 1985, the General 
Product Safety Regulations 2005 (GPSR) and Consumer Protection from Unfair Trading 
Regulations 2008 (CPUTR). 
As aforementioned, one of the controls that superseded the Psychoactive Substances 
Act 2016 was the Intoxicating Substances Act 1985. Whereby it was “an offence for a person 
to supply or offer to supply a substance other than a controlled drug, to a person under the 
age of eighteen whom he knows, or has reasonable cause to believe, to be under that age” 
(Intoxicating Substance (Supply) Act 1985, Ch. 1, s. 1, ss. a). The effects of this in restricting 
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supply can be seen with a case study from September 2014. A ‘head shop’ – an outlet selling 
paraphernalia associated with tobacciana, was found to be selling NPS to children. It was 
made clear by the 16-year-olds who were sent into the shop they were underage and asked 
the proprietor how to consume the NPS.  
The proprietor sold to the 16-year-old on each of the five occasions they were sent in 
undercover, the defendant received a three-month custodial sentence (suspended for two 
years), an 18-month supervision order and 120 hours of community service (Home Office, 
2015). Along with home office undercover operations, the mass media also sent undercover 
operatives, which will be discussed later in this chapter. 
An important control was derived from the protection of the consumer. Two key 
regulations to protect consumers in regard to NPS before the Psychoactive Substances Act 
2016 were the General Product Safety Regulations 2005 (GPSR) and Consumer Protection 
from Unfair Trading Regulations 2008 (CPUTR). Whilst regulations are not as definitive as a 
law, they are still useful in protecting public health. 
The GPSR aims to protect the consumer by ensuring that the products being sold are 
‘safe’, i.e., being a substance, which has a minimal-to-no risk of causing ill-effects when the 
substance is used within the remit of normal use. Two major regulations within the GPSR are 
regulations 5 & 8, which places the onus of safety upon the producer and distributor 
respectively.  
As is stated in regulation 5(1), “No producer shall place a product on the market 
unless the product is a safe product” (General Product Safety Regulations, 5(1), 2005). 
Regulation 8, states;  
“(1) A distributor shall act with due care in order to help ensure compliance with the 
applicable safety requirements and in particular he—  
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(a) shall not expose or possess for supply or offer or agree to supply, or supply, a product 
to any person which he knows or should have presumed, on the basis of the information in 
his possession and as a professional, is a dangerous product; and 
(b) shall, within the limits of his activities, participate in monitoring the safety of a product 
placed on the market, in particular by— 
(i) passing on information on the risks posed by the product.” 
This is vital as the distributer being the head shop, the responsibility is down to the 
proprietor to ensure they are supplying a safe product and they are safeguarding the 
consumer by supplying the full safety associated with the product. As aforementioned, the 
mass media sent undercover operatives into head shops to see if the proprietor committed 
an offence under the Intoxicating Substances (Supply) Act 1985, as part of ‘The Kyle Files’ – a 
post watershed investigatory programme, an underage child was sent in to a head shop to 
test a range of safety precautions which should have been in place (The Kyle Files, 2015). Not 
only was the owner in breach of the Intoxicating Substances (Supply) Act 1985, he also failed 
to sufficiently explain the full dangers of taking NPS.  This highlights how that not only head 
shops were not keeping within the safety precautions they should, but also how the media 
was exploring this issue and presenting it to a larger audience.   
The main issue with prosecuting following a breach of regulations 5 & 8, is showing 
that to the criminal standard the producer/distributor had sold the substances knowing that 
the intent of the purchaser was to consume the product and that the product itself was 
dangerous. The issue with showing that the product was not dangerous is complex; with the 
vast nature of the products available and the ever-changing product range it would be 
difficult to trace the substance. Equally, had the producer/distributor sold it knowing the 
intent on the purchaser was not to consume it - but eventually did, the producer/distributer 
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knew the substance not to be dangerous if left untaken and could not be responsible as they 
sold it on the knowledge the person was not going to misuse it. 
Another vital consumer protection given from the GSPR is the, ‘requirement to mark’. 
The requirement to mark is given by regulation 12 of the GSPR.  
If the local authority so deems a substance to be of danger to public health, the requirement 
to mark means the distributor must label the substance displaying the appropriate risks 
associated with the product. The flaw within this regulation, however, is the fact that no 
central government is ruling this. As it is down to the local jurisdiction to deem something as 
dangerous or not, one county may require to mark whereas another county may believe the 
substance to be safe. 
An expansion upon regulation 8, which makes the distributer pass on all information 
regarding the safety of the product, regulation 13 is the ‘requirement to warn’. This, like 
regulation 12, gives the local authority the power to deem a substance as dangerous and 
serve a notice to the distributer that they should be required to give a warning to the 
consumer this product has been deemed dangerous (General Product Safety Regulations 
2005). 
Further consumer protection is given from the Consumer Protection from Unfair 
Trading Regulations 2008 (CPUTR). The main points given from the CPUTR are to protect the 
consumer from the practices of deception i.e., the shop claiming to be ‘endorsed’ or 
‘authentic’, when in fact there is no authorising body, for example. The packaging must not 
be misrepresentative of the contents, it cannot claim to be a substance it is not. The 
packaging may also not be deceptive in the branding in such a way that the packaging would 
make the consumer take the transactional decision they may not have under standard trading 
conditions (Consumer Protection from Unfair Trading Regulations, 5(2), 2008.) 
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Despite these laws and regulations in place to protect the public from dangerous 
substances, harm still continued to the public and in December 2013, Mr Norman Baker 
announced the commission of the New Psychoactive Substances Review Expert Panel, noting 
the need for a review to protect the public health (HC written statement, 12 December 2013). 
Previous to the announcement of the review, there had been debate in the house of 
common on the best way to control these substances should a ban be implemented. The first 
suggestion by the member for Bassetlaw, John Mann was to implement a full ban on all 
psychoactive substances. The member for Cambridge, Dr Julian Huppert highlighted to the 
house, should an entire blanket ban be implemented then the coffee or tea the members had 
drank before coming to the house would be illegal as caffeine is a psychoactive substance (HC 
Deb, 11 November 2013). This is vital in showing the need for parliament to take advice on a 
nuanced area of expertise; this then led to Norman Baker convening the expert panel.  
The recommendations of the panel have been previously discussed in chapter 4.4, 
the Psychoactive Substances Act was given its royal assent on 28 January 2016, with it 
becoming enforced on 26 May 2016. Whilst the act was successful in shutting down head 
shops and limiting accessibility to these substances, there were still criticisms to the act.  
Stevens et al. (2015), highlighted the issue with the sentencing aspect of the bill. The 
sentencing powers at the time regarding drug cases, the judge used their discretion to 
impose a higher sentence on a drug deemed of ‘higher harm’. With the Psychoactive 
Substances Bill, it is less likely for judges to understand which substance was of higher danger, 
therefore a proportional sentence was unlikely to happen.  
In 2015, the ACMD highlighted an issue with the definition of psychoactive, within the 
bill. Whilst drugs similar in structure may have the same action, this cannot be proven 
without the in vitro study of psychoactivity (ACMD, 2015). Although, this was left ambiguous 
by lawmakers so that new substances could be banned without extensive testing. 
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Another criticism was the so-called ‘displacement effect’ which was seen in 2010 with 
mephedrone. Before the ban of mephedrone, it was seen that users of classified stimulants - 
such as MDMA and cocaine, started to change from an impure cut-down street product to 
stimulants like mephedrone, which were much more likely to be a pure sample  
(Measham et al., 2010). It was then feared that with the introduction of the Psychoactive 
Substances Act 2016, that this displacement effect would be even more pronounced (ACMD, 
2015). 
The criticisms facing the bill were mostly suppositions and based upon evidence of 
previously banned substances, the full extent of the effects would only be seen after the act 
was implemented. 
Post-introduction of the Act 
In the review by the Home Office as was required by the act, the Home Office says 
that the scene for the selling of these substances had changed; moving from shops to online 
selling (Home Office, 2018). With the digital revolution and the transition to the ‘Information 
Age’ (Castells, 1996) the populous of the internet has turned the drug scene from a street one 
to a virtual one (Orsolini et al, 2016). The question therefore is, was this change in the scene a 
natural progression or was it catalysed in the UK by the introduction of the Psychoactive 
Substances Act 2016?  
The review states that it is difficult to measure but what is clear from the Crime 
Survey for England and Wales, the internet is still an important source of drugs for users 
(CSEW, 2018). The criticism is that by taking the NPS scene from the street to underground 
cause more harm as there was no regulation. As previously discussed in this chapter though, 
whilst there were some regulations in place, they were not entirely effective. In 2015, 114 
deaths were recorded in relation with NPS; this raised to 123 deaths in 2016, but in 2017 this 
was reduced to 61 deaths (Office for National Statistics, 2017). This seems to be important as 
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when unregulated the deaths from NPS was rising, however once regulated it nearly halved 
(49.6% reduction).  
 
In the Crime Survey for England and Wales, there was a reported reduction in the use 
of NPS amongst adults 18 – 59 years-old following the introduction of the Psychoactive 
Substances Act 2016. In 2015, use amongst the population was 1.1%, in 2016 this reduced to 
0.6% and in 2017 further reduced to 0.5%, this is a reduction of 0.5% and 0.1% respectively 
year-to-year (CSWE, 2017). However, whilst this household survey has reported positive 
affects following the introduction of the act, there may not be all positive effects. 
Addaction, a charity with a focus on aiding those with habitual use or addiction with 
substances, in 2017 released a report with a focal point on the health of young people, and 
their use of NPS. They had a self-submitted online survey for young people aged 16-25 to 
garner information about the use of NPS amongst this demographic. The survey took place in 
the autumn of 2016, so a few months after the introduction of the Psychoactive Substances 
Act 2016. The young people reported that the Psychoactive Substances Act 2016 had not 
deterred them from taking NPS, only that it made it harder to access and more expensive. 
They also reported as they now had to visit a dealer to get the NPS, they would also be more 
likely to get classical drugs of abuse at the same time. In a study of a Norfolk school, it was 
revealed that students in 2018 were still taking NPS. 8.7% of respondents had reported use of 
NPS, so this may support the findings of addiction (Roderick et al., 2018).   
NPS are still being produced outside of the UK; designer benzodiazepines (BZD) have become 
increasingly popular (Zawliska and Wojcieszak, 2019). Whilst deaths still occur from the use of 
NPS (Koch et al., 2018), with this new influx of designer BZD having the Psychoactive 
Substances Act in place means that all designer BZD imported into the UK are immediately 
illegal. This means the UK Government is no longer having to ‘catch its tail’ to keep all these 
different compounds banned.  
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Alongside this is the previous attempt of sellers to circumvent the regulations was to 
label NPS as ‘plant food’ or such the like (Beharry and Gibbons, 2016). Following the 
introduction of the Psychoactive Substances Act 2016, there is no circumvention.  
Such is the example of Phenibut, a medication in Russia, it is not scheduled in UK so is often 
labelled as a health supplement. As it is a known psychoactive substance, should a person 
import it as a health supplement they will be breaking the law. It is only illegal however, 
should a person import it, the possession of the substance is not, this will be discussed further 
in chapter 7. 
Discussion 
From this study, it can be concluded that the use of handheld Raman is possible to 
test samples of NPS. It appeared there was no masking of the sample’s active ingredient by 
additives, when sampling NPS, as a pharmaceutically active ingredient appeared in all spectral 
groups. As previously mentioned, Raman is a surface-level technique, so will only yield results 
from the surface. If that means the additive is more Raman active that the active ingredient 
there will be masking of the samples active ingredient’s spectrum. As a result, Raman can be 
problematic when used to analyse a mixture, especially when concerning classical drugs 
which are often adulterated by ‘cutting’ (Preble and Casey, 1972). This is where the pure form 
is adulterated with cheaper bulking agents; this could happen at each stage of the distribution 
process. Moreover, with NPS, the producer would press the substance into a pallet, pill or 
tablet (Vice, 2017).  
This means there are fewer bulking agents as it is not broken down and bulked at 
each stage of distribution, therefore less likely to mask any spectra.  
With the use of Raman to analyse the contents of samples, it gave useful primary information 
about what was being taken at Glastonbury in 2011. It should however be noted that this is a 
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small representation of what was being taken, this being two-fold. Firstly, not all samples are 
Raman active or able to be scanned by the Raman Analyser.  
Those substances which are blotted onto paper cannot be analysed, as the laser is 
too powerful and will char the paper.  
In the sample boxes were mushrooms, which species origin still remains unknown however 
they could not be scanned as organic material will char, as again the laser is too powerful. 
Whilst mushrooms would need to be analysed via different means as most instrumental 
techniques would struggle, the point remains for a substance like black-tar heroin, or such the 
like that Raman would be unable to analyse these types of samples. This is complementary to 
the guidelines given by the UN in the document titled, “Guidelines on Raman Handheld Field 
Identification Devices for Seized Material” 
Secondly, these samples are only what people have discarded. Whilst it is hoped that the 
samples taken and scanned are representative of what was being used en masse, it has also 
shown that there was not a high amount of NPS use during a time when a high usage was 
supposed. This is why it has been vital during this research to use secondary sources, to gain a 
proper sight of what was happening during at that time.  
Whilst the use of secondary sources has been vital for contemporaneous 
commentary, the use of secondary sources of information comes with some issues. 
Secondary sources of information especially from the mass media may not be accurate. When 
regarding the mass media, freedom of the press allows the author to express their opinions 
without interference (UN General Assembly, 1948). This means that secondary sources of 
information can be presented as fact but maybe somebody’s opinion. Also, some sources for 
the mass media are anecdotal, i.e. a personal account from a member of the public; which 
will be biased, so whilst anecdotal evidence can be incredibly informative it should be used 
with caution. 
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Secondly, ‘Publish or Perish’ is a term used in academia to describe the need to 
continue research and publishing to continue on a career path (Doyle et al., 2012). This has 
led to research that may have been rushed and is not entirely reliable, because of this the 
secondary sources need to be reviewed before inclusion.  
The reviewing process is to find many sources that corroborate the same idea, should many 
sources present the same results then there is a higher chance of them being good sources. 
Should there be a single source of information, presenting its own evidence with little-to-no 
other sources then it should be excluded. However, on the whole most of the sources used 
for this have been concurrent with one another, but it is still a risk that needs to be identified 
whilst working for optimum results. 
Conclusion 
Taking all of this into consideration, the trends around NPS have been assessed. It can 
be concluded that there was indeed a mass influx of these substances being imported and 
used in the UK. The government set out in 2013 to fully assess the best way to deal with this 
problem that was arising. This culminated in the Psychoactive Substance Act 2016, with the 
view to protect the general public by restricting access to these substances. The statistics 
shows that the Act was successful as head shops are now closed and the statistics are 
showing a reduction in deaths related with NPS. The Psychoactive Substances Act 2016 
differed from that of the Misuse of Drugs Act 1971 by the fact there is no crime for 
possession - except in a custodial setting, of a psychoactive substance under the Psychoactive 
Substances Act 2016. This shows that the law aimed to directly limit the sale and production 
of NPS to reduce harm to the general public. Whilst it may not have acted as a deterrent to 
habitual users, it has stopped the average member of the public from gaining access to such 
substances. On the whole the Act has been successful in its aims in reducing the harm and 
protecting the public. 
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Further work could be taken in conjunction with this work. During this Raman was 
used in the rapid-scanning of samples, although due to constraints it wasn’t possible to 
confirm the identification of substances with the use of control samples. In further work, 
these would be scanned, alongside common cutting agents.  
With additional scanning, it could be possible to fully assess how additives can affect the 
Raman spectrum. Gas Chromatography-Mass Spectrometry could also be utilised to assess 
how accurate the identification via Raman is. This would be helpful as chromatography will 
separate out each component, which could greater inform the spectroscopy. Overall, this 
research project has shown positive aspects into the use Raman spectroscopy in rapid-
scanning of NPS, which can be expanded on with complementary research as discussed. 
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Appendix A – All scree plots 
A1 – Scree plot for Batch A of substances scanned taken from the amnesty bins at the Glastonbury 
Festival 2011. 
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A2 - Scree plot for Batch B of substances scanned taken from the amnesty bins at the 
Glastonbury Festival 2011. 
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A3 - Scree plot for Batch C of substances scanned taken from the amnesty bins at the 
Glastonbury Festival 2011. 
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A4 - Scree plot for Batch D of substances scanned taken from the amnesty bins at the 
Glastonbury Festival 2011. 
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A5 - Scree plot for all batches of substances scanned taken from the amnesty bins at the 
Glastonbury Festival 2011. 
